Surgical Quality Improvement

Brain Tumor Surgery Outcomes

Brain Tumor Surgery ACS NSQIP Outcomes

January 1, 2020 – December 31, 2020

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall brain tumor surgery ACS NSQIP performance benchmarked against 226 participating sites.

Brain Tumor (226 Sites)NObservedExpected
30 Day Mortality2381.26%1.87%
30 Day Morbidity23812.61%10.33%
Cardiac 2380.84%0.62%
Pneumonia2382.10%1.90%
Unplanned Intubation2382.94%1.91%
Ventilator > 48 Hours2382.52%1.66%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus2384.20%3.92%
Urinary Tract Infection (UTI)2381.68%1.32%
Surgical Site Infection (SSI)2383.78%2.08%
Sepsisᵃ2384.20%1.77%
Return to Operating Room (ROR)2385.04%5.24%

American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.